Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

QR Code

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Background and Aims Colorectal cancer (CRC) screening decisions for elderly individuals are often made primarily on the basis of age, whereas other factors that influence the effectiveness and cost effectiveness of screening are often not considered. We investigated the relative importance of factor...

Full description

Bibliographic Details
Main Authors:	Van Hees, F., Saini, S., Lansdorp_Vogelaar, Iris, Vijan, S., Meester, R., De Koning, H., Zauber, A., Van Ballegooijen, M.
Format:	Journal Article
Published:	W.B. Saunders Co. 2015
Online Access:	http://hdl.handle.net/20.500.11937/50113

Similar Items

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Personalizing age of cancer screening cessation based on comorbid conditions: Model estimates of harms and benefits
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)

Population-Based colonoscopy screening for colorectal cancer : A randomized clinical trial
by: Bretthauer, M., et al.
Published: (2016)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling
by: Kroep, S., et al.
Published: (2015)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Optimising patient risk stratification for colonoscopy screening and surveillance of colorectal cancer: The role for linked data
by: O'Leary, Peter, et al.
Published: (2017)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Cost effectiveness of surveillance for GI cancers
by: Omidvari, A., et al.
Published: (2016)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)

Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)

Radiation-related cancer risks from CT colonography screening: A risk-benefit analysis
by: Berrington De González, A., et al.
Published: (2011)